Phibro Animal Health (PAHC) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corporation Reports Third Quarter Results
May 7, 2020 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2020.
Highlights for the March 2020 quarter (compared to the March 2019 quarter)
Net sales of $211 million, an increase of $5 million, or 2% Net income of $14 million, a decrease of $1 million, or 9% Diluted EPS of $0.33, a decrease of $0.04, or 11% Adjusted EBITDA of $30 million, comparable to the prior year quarter Adjusted diluted EPS of $0.38, a decrease of $0.01, or 3%COMMENTARY
"The... More



